These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20684157)

  • 1. Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses.
    Burnett TJ; English JC; Ferris LK
    J Drugs Dermatol; 2010 Aug; 9(8):1022-4. PubMed ID: 20684157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.
    Quist SR; Gollnick HP
    Expert Opin Pharmacother; 2011 Feb; 12(3):451-61. PubMed ID: 21254950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod-induced subacute cutaneous lupus erythematosus-like changes.
    Maguiness SM; Farsani TT; Zedek DC; Berger TG
    Cutis; 2015 Jun; 95(6):349-51. PubMed ID: 26125212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis.
    Rowlands MA; Giacometti JN; Servat J; Materin MA; Levin F
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):e21-e23. PubMed ID: 25853505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
    Swanson N; Smith CC; Kaur M; Goldenberg G
    J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zyclara (imiquimod) cream, 3.75%.
    Gupta AK; Cooper EA; Abramovits W
    Skinmed; 2010; 8(4):227-9. PubMed ID: 21137610
    [No Abstract]   [Full Text] [Related]  

  • 7. [New perspective in immunotherapy: local imiquimod treatment].
    Kemény L; Nagy N
    Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod 5% cream for the treatment of actinic keratoses.
    Somani N; Rivers JK
    Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod cream in the treatment of actinic keratoses.
    Persaud A; Lebwohl M
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus erythematosus-like imiquimod reaction: a diagnostic pitfall.
    Barr KL; Konia TH; Fung MA
    J Cutan Pathol; 2011 Apr; 38(4):346-50. PubMed ID: 20726930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of recalcitrant skin ulcers as a side-effect of treatment with topical 5% imiquimod cream: report of two cases.
    Kalampalikis A; Goetze S; Elsner P
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1574-6. PubMed ID: 24456017
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of imiquimod-induced alopecia.
    Conde J; Davis K; Ntuen E; Balmer N; Jones D; McMichael A
    J Dermatolog Treat; 2010 Mar; 21(2):122-4. PubMed ID: 19488918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists.
    Strohal R; Kerl H; Schuster L
    J Drugs Dermatol; 2012 May; 11(5):574-8. PubMed ID: 22527424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream.
    Shaffelburg M
    J Drugs Dermatol; 2009 Jan; 8(1):35-9. PubMed ID: 19180894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imiquimod-induced hypopigmentation following treatment of periungual verruca vulgaris.
    Edgar N; Pilkington S; Hogan DJ
    Cutis; 2018 Jun; 101(6):466-468. PubMed ID: 30063776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe reaction to 5% imiquimod cream with excellent clinical and cosmetic outcomes.
    Greenberg HL; Cohen JL; Rosen T; Orengo I
    J Drugs Dermatol; 2007 Apr; 6(4):452-8. PubMed ID: 17668546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
    Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
    J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.
    Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
    J Transl Med; 2007 Jan; 5():7. PubMed ID: 17257431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
    Gebauer K; Shumack S; Cowen PS
    Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.